{"disease":{"id":"traveler-s-diarrhea","name":"Traveler's diarrhea","therapeutic_area":"","data":{},"enrichment_level":0,"last_enriched_at":null,"visit_count":0,"created_at":"2026-04-19T18:31:21.150Z","updated_at":"2026-04-19T18:39:44.960Z","meddra_pt":null,"meddra_code":null,"icd10_codes":null,"synonyms":[],"prevalence_global":null,"prevalence_us":null,"marketed_drug_count":1,"pipeline_drug_count":0,"trial_count":0},"drugs":{"marketed":[{"drug_id":"loperamide","indication_name":"Traveler's diarrhea","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Imodium","generic_name":"loperamide","company_name":"Johnson & Johnson (McNeil Consumer Healthcare)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Cocaine esterase, D(4) dopamine receptor","drug_class":"Antidiarrheal (peripheral opioid agonist)","quality_score":null,"revenue":null,"mechanism":"Peripheral mu-opioid receptor agonist that slows intestinal motility and increases fluid absorption without crossing the blood-brain barrier."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06363890","title":"Etiology of Travelers' Diarrhea in Australian Tourists Traveling to Southeast Asia","phase":"","overall_status":"RECRUITING","enrollment_count":1200,"lead_sponsor_name":"Lumen Bioscience, Inc.","has_results":false},{"nct_id":"NCT03866291","title":"ESBL in Patients Returning to Sweden With Traveller's Diarrhoea","phase":"","overall_status":"COMPLETED","enrollment_count":305,"lead_sponsor_name":"Lund University","has_results":false},{"nct_id":"NCT03301103","title":"PTM202 and Modulation of Host Resistance to Diarrheagenic E. Coli","phase":"NA","overall_status":"COMPLETED","enrollment_count":72,"lead_sponsor_name":"NIZO Food Research","has_results":false},{"nct_id":"NCT05933525","title":"Clinical Study to Assess the Efficacy of IMM-124E (Travelan®) in a Controlled Human Infection Model","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"Immuron Ltd.","has_results":false},{"nct_id":"NCT00524004","title":"Safety and Efficacy of Bovine Milk Immunoglobulin Against CS17 and CsbD","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":36,"lead_sponsor_name":"Johns Hopkins Bloomberg School of Public Health","has_results":false},{"nct_id":"NCT02920242","title":"A Study Comparing Two Rifaximin Tablets in Patients With Travelers' Diarrhea.","phase":"PHASE3","overall_status":"TERMINATED","enrollment_count":28,"lead_sponsor_name":"Sandoz","has_results":true},{"nct_id":"NCT06556940","title":"G.I. Pharmacokinetics of LMN-401 in Individuals With Ileostomies","phase":"EARLY_PHASE1","overall_status":"RECRUITING","enrollment_count":12,"lead_sponsor_name":"Lumen Bioscience, Inc.","has_results":false},{"nct_id":"NCT02736539","title":"Clinical Trial of CBS-2004 in Prevention of Travelers' Diarrhea","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Clasado Biosciences Ltd","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}